Literature DB >> 25366655

Quantification of liver herniation in fetuses with isolated congenital diaphragmatic hernia using two-dimensional ultrasonography.

I S Werneck Britto1,2, O O Olutoye1,2,3, D L Cass1,3, I J Zamora1,3, T C Lee1,3, C I Cassady1,4, A Mehollin-Ray1,4, S Welty1,5, C Fernandes1,5, M A Belfort1,2, W Lee1,2, R Ruano1,2.   

Abstract

OBJECTIVES: To describe a method of quantifying the amount of liver herniation in fetuses with isolated congenital diaphragmatic hernia (CDH) using two-dimensional ultrasonography and to correlate this finding with neonatal outcome.
METHODS: Ultrasound images obtained from 77 consecutive fetuses that presented with isolated CDH between January 2004 and July 2012 were reviewed. Liver herniation and thoracic area were measured in a cross-sectional plane of the fetal chest at the level of the four-chamber view of the heart (the same section as is used to measure the lung area-to-head circumference ratio) and the ultrasound-derived liver-to-thoracic area ratio (US-LiTR) was calculated by dividing the liver herniation area by the thoracic area. Receiver-operating characteristics (ROC) curve analysis was used to evaluate the performance of US-LiTR in predicting neonatal outcome (survival to 6 months after delivery and need for extracorporeal membrane oxygenation (ECMO)). In addition, the US-LiTR was compared with the magnetic resonance imaging (MRI)-derived volume ratio (MRI-LiTR) and percentage of liver herniation (MRI-%LH).
RESULTS: The overall neonatal mortality in the 77 cases with isolated CDH was 20.8% (16/77). ECMO was needed in 35.5% (27/76) of the newborns, with a survival rate of 52%. The US-LiTR was associated statistically with mortality (P < 0.01) and with the need for ECMO (P < 0.01). Good correlations were observed between US-LiTR and MRI-LiTR (r = 0.87; P < 0.001) and between US-LiTR and MRI-%LH (r = 0.90; P < 0.001). Based on ROC curve analysis, all three parameters had similar accuracy in predicting mortality (US-LiTR: area under the ROC curve (AUC), 0.78 (95% CI, 0.65-0.92), P < 0.01; MRI-LiTR: AUC, 0.77 (95% CI, 0.63-0.90), P < 0.01; MRI-%LH: AUC, 0.79 (95% CI, 0.65-0.92), P < 0.01, respectively) as well as the need for ECMO (US-LiTR: AUC, 0.72 (95% CI, 0.60-0.84), P < 0.01; MRI-LiTR: AUC, 0.73 (95% CI, 0.60-0.88), P < 0.01; MRI-%LH: AUC, 0.77 (95% CI, 0.64-0.89), P < 0.01, respectively).
CONCLUSIONS: Two-dimensional ultrasound measurement of the amount of liver herniation in fetuses with isolated CDH is feasible and demonstrates a predictive accuracy for neonatal outcome similar to that of MRI.
Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  congenital diaphragmatic hernia; fetal therapy; liver herniation; lung-to-head ratio; prenatal diagnosis; pulmonary hypoplasia; ultrasound

Mesh:

Year:  2015        PMID: 25366655     DOI: 10.1002/uog.14718

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  3 in total

1.  The validity of the observed-to-expected lung-to-head ratio in congenital diaphragmatic hernia in an era of standardized neonatal treatment; a multicenter study.

Authors:  Kitty G Snoek; Nina C J Peters; Joost van Rosmalen; Arno F J van Heijst; Alex J Eggink; Esther Sikkel; René M Wijnen; Hanneke IJsselstijn; Titia E Cohen-Overbeek; Dick Tibboel
Journal:  Prenat Diagn       Date:  2017-06-01       Impact factor: 3.050

2.  The interplay between prenatal liver growth and lung development in congenital diaphragmatic hernia.

Authors:  Katherine C Ott; Michael Bi; Federico Scorletti; Saad A Ranginwala; William S Marriott; Jose L Peiro; Beth M Kline-Fath; Amir M Alhajjat; Aimen F Shaaban
Journal:  Front Pediatr       Date:  2022-09-26       Impact factor: 3.569

3.  Reference range of fetal thorax using two-dimensional and three-dimensional ultrasound VOCAL technique and application in fetal thoracic malformations.

Authors:  Xihua Lian; Zhenhong Xu; Liping Zheng; Zhixing Zhu; Tofunmi Ejiwale; Ayush Kumar; Peiya Cai; Shaozheng He; Shunlan Liu; Ying Zhang; Guorong Lyu
Journal:  BMC Med Imaging       Date:  2021-02-22       Impact factor: 1.930

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.